NED
CELG

Nancy E. Dempze’s Celgene Corp CELG Stock Holding History

Nancy E. Dempze’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,504
Closed -$1.03M – 76
2018
Q3 		$1.03M Buy
11,504
+1,410
+14% +$125K 1.15% 30
2018
Q2 		$803K Buy
10,094
+2,520
+33% +$209K 0.98% 31
2018
Q1 		$675K Buy
7,574
+4,624
+157% +$444K 0.83% 34
2017
Q4 		$308K Buy
2,950
+550
+23% +$62.1K 0.37% 63
2017
Q3 		$350K Hold
2,400
– – 0.49% 54
2017
Q2 		$312K Hold
2,400
– – 0.45% 62
2017
Q1 		$299K Hold
2,400
– – 0.46% 63
2016
Q4 		$278K Hold
2,400
– – 0.49% 66
2016
Q3 		$251K Hold
2,400
– – 0.44% 66
2016
Q2 		$237K Hold
2,400
– – 0.42% 72
2016
Q1 		$240K Hold
2,400
– – 0.42% 73
2015
Q4 		$287K Buy
+2,400
New +$278K 0.55% 64

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nancy E. Dempze's CELG Position: Q4 2018 in Review

Nancy E. Dempze sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 11,504 shares — an estimated $1.03M sold.

Nancy E. Dempze first reported a position in CELG in Q4 2015 and held it in 12 quarters. The position peaked at $1.03M in Q3 2018. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Nancy E. Dempze reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Nancy E. Dempze sold 11,504 Celgene Corp shares in Q4 2018, an estimated $1.03M.
  • Nancy E. Dempze first reported a position in Celgene Corp in Q4 2015 and held it in 12 quarters.
  • Nancy E. Dempze's Celgene Corp position peaked at $1.03M in Q3 2018.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Nancy E. Dempze's 13F filing for Q4 2018, filed 24 Jan 2019.